News Features FFR’s Future: Negative Trials Spur Debate Over Technology’s Role Michael O'Riordan December 23, 2021
News Daily News Statins Underprescribed in PAD Before and After Interventions L.A. McKeown December 03, 2021
News Conference News AXIOMATIC-TKR: Milvexian Promising for VTE Prevention L.A. McKeown November 15, 2021
News Conference News TCT 2021 Debating ISCHEMIA: Do the Results Apply to CABG, Too? Michael O'Riordan November 10, 2021
News Conference News TCT 2021 Good Early Outcomes With PCI in Complex Patients Unsuited to Surgery: OPTIMUM Michael O'Riordan November 04, 2021
News Conference News ACC 2021 Complete Revascularization Analysis of ISCHEMIA Opens ‘Pandora’s Box’ Michael O'Riordan May 18, 2021
News Daily News Potent Antiplatelets Pre-CABG for ACS? Meta-analysis Stirs Debate L.A. McKeown February 26, 2021
News Daily News In ISCHEMIA, Stable CAD Treatment Effect Hinged on MI Definition Michael O'Riordan December 11, 2020
News Features Too Easy to Misconstrue: Is It Time to Ditch Periprocedural MI? Michael O'Riordan December 02, 2020
News Daily News ‘Frailty Meter’ May Aid Treatment Decisions in Chronic Limb-Threatening Ischemia L.A. McKeown November 24, 2020
News Daily News Bariatric Surgery Tied to Better Long-term Outcomes After MI Todd Neale October 27, 2020
News Conference News EuroPCR 2020 No Survival Benefit With Revascularization in Stable CAD, Meta-analysis Confirms Michael O'Riordan June 26, 2020
News Daily News Meta-analysis Questions PCI vs CABG in Women With Multivessel Disease Shelley Wood February 27, 2020
News Daily News Revascularization After PCI or CABG Linked to Higher Mortality: EXCEL Michael O'Riordan January 17, 2020
News Opinion Editor's Corner ISCHEMIA Questions? Some Answers From David Maron Shelley Wood December 09, 2019
News Daily News Cannabis Abuse Linked to Periprocedural MIs After Elective Surgeries Shelley Wood December 03, 2019
News Daily News Vasospasm, Microvascular Dysfunction Tied to MACE in Nonobstructive CAD Michael O'Riordan November 05, 2019
News Daily News Evolocumab Safe and Effective Out to 5 Years: OSLER-1 Yael L. Maxwell October 22, 2019